Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction

References

• Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197–210. doi:10.1016/s0140-6736(16)30677-8
   PubMed Web of Science ®Google Scholar
• Marín-Juez R, El-Sammak H, Helker CSM, et al. Coronary revascularization during heart regeneration is regulated by epicardial and endocardial cues and forms a scaffold for cardiomyocyte repopulation. Dev Cell. 2019;51(4):503–515.e4. doi:10.1016/j.devcel.2019.10.019
   PubMedGoogle Scholar
• Rentrop KP, Feit F. Reperfusion therapy for acute myocardial infarction: concepts and controversies from inception to acceptance. Am Heart J. 2015;170(5):971–980. doi:10.1016/j.ahj.2015.08.005
   PubMed Web of Science ®Google Scholar
• Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125(9):1147–1156. doi:10.1161/circulationaha.111.047431
   PubMed Web of Science ®Google Scholar
• Ou LC, Zhong S, Ou JS, Tian JW. Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis. Acta Pharmacol Sin. 2021;42(1):10–17. doi:10.1038/s41401-020-0436-0
   PubMed Web of Science ®Google Scholar
• Gorabi AM, Kiaie N, Reiner Ž, Carbone F, Montecucco F, Sahebkar A. The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis. Biomolecules. 2019;9(9):2545. doi:10.3390/biom9090416
   Google Scholar
• Young DR, Hivert MF, Alhassan S, et al. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation. 2016;134(13):e262–79. doi:10.1161/cir.0000000000000440
   PubMed Web of Science ®Google Scholar
• Ekroos K, Jänis M, Tarasov K, Hurme R, Laaksonen R. Lipidomics: a tool for studies of atherosclerosis. Curr Atheroscler Rep. 2010;12(4):273–281. doi:10.1007/s11883-010-0110-y
   PubMedGoogle Scholar
• Meneghini BC, Tavares ER, Guido MC, et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascul Pharmacol. 2019;115:46–54. doi:10.1016/j.vph.2019.02.003
   PubMed Web of Science ®Google Scholar
• Bulgarelli A, Martins Dias AA, Caramelli B, Maranhão RC. Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits. J Cardiovasc Pharmacol. 2012;59(4):308–314. doi:10.1097/FJC.0b013e318241c385
   PubMed Web of Science ®Google Scholar
• Cervadoro A, Palomba R, Vergaro G, et al. Targeting inflammation with nanosized drug delivery platforms in cardiovascular diseases: immune cell modulation in atherosclerosis. Front Bioengineering Biotechnol. 2018;6:177. doi:10.3389/fbioe.2018.00177
   PubMed Web of Science ®Google Scholar
• Zhang J, Zu Y, Dhanasekara CS, et al. Detection and treatment of atherosclerosis using nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(1). doi:10.1002/wnan.1412
   Web of Science ®Google Scholar
• Schmid P, Adams S, Rugo HS, et al. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2018;379(22):2108–2121. doi:10.1056/NEJMoa1809615
   PubMed Web of Science ®Google Scholar
• Bahadur S, Sachan N, Harwansh RK, Deshmukh R. Nanoparticlized system: promising approach for the management of alzheimer’s disease through intranasal delivery. Curr Pharm Des. 2020;26(12):1331–1344. doi:10.2174/1381612826666200311131658
   PubMedGoogle Scholar
• Wang W, Liu H, Lu Y, et al. Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia-reperfusion injury. Int J Nanomedicine. 2019;14:875–888. doi:10.2147/ijn.S186225
   PubMed Web of Science ®Google Scholar
• Banik B, Surnar B, Askins BW, Banerjee M, Dhar S. Dual-targeted synthetic nanoparticles for cardiovascular diseases. ACS Appl Mater Interfaces. 2020;12(6):6852–6862. doi:10.1021/acsami.9b19036
   PubMedGoogle Scholar
• Yokoyama R, Ii M, Masuda M, et al. Cardiac regeneration by statin-polymer nanoparticle-loaded adipose-derived stem cell therapy in myocardial infarction. Stem Cells Transl Med. 2019;8(10):1055–1067. doi:10.1002/sctm.18-0244
   PubMedGoogle Scholar
• Wang J, Xiang B, Deng J, et al. Externally applied static magnetic field enhances cardiac retention and functional benefit of magnetically iron-labeled adipose-derived stem cells in infarcted hearts. Stem Cells Transl Med. 2016;5(10):1380–1393. doi:10.5966/sctm.2015-0220
   PubMedGoogle Scholar
• Gadde S, Rayner KJ. Nanomedicine Meets microRNA: current Advances in RNA-Based Nanotherapies for Atherosclerosis. ACS Nano. 2016;36(9):e73–9. doi:10.1161/atvbaha.116.307481
   Google Scholar
• Sun Y, Lu Y, Yin L, Liu Z. The roles of nanoparticles in stem cell-based therapy for cardiovascular disease. Int J Nanomedicine. 2020;8:947. doi:10.3389/fbioe.2020.00947
   Google Scholar
• Liu S, Chen X, Bao L, et al. Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat Biomed Eng. 2020;4(11):1063–1075. doi:10.1038/s41551-020-00637-1
   PubMed Web of Science ®Google Scholar
• Pitek AS, Wang Y, Gulati S, et al. Elongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies. Mol Pharm. 2017;14(11):3815–3823. doi:10.1021/acs.molpharmaceut.7b00559
   PubMedGoogle Scholar
• Won YW, McGinn AN, Lee M, Bull DA, Kim SW. Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier. Article. Mol Pharm. 2013;10(1):378–385. doi:10.1021/mp300500y
   PubMedGoogle Scholar
• Sink E, Narayan SP, Abdel-Hafiz M, Mestroni L, Peña B. Nanomaterials for cardiac tissue engineering. Molecules. 2020;25(21). doi:10.3390/molecules25215189
   PubMedGoogle Scholar
• Zhang CX, Cheng Y, Liu DZ, et al. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats. J Nanobiotechnology. 2019;17(1):18. doi:10.1186/s12951-019-0451-9
   PubMed Web of Science ®Google Scholar
• Oduk Y, Zhu W, Kannappan R, et al. VEGF nanoparticles repair the heart after myocardial infarction. Am J Physiol Heart Circ Physiol. 2018;314(2):H278–h284. doi:10.1152/ajpheart.00471.2017
   PubMedGoogle Scholar
• Caldas M, Santos AC, Veiga F, Rebelo R, Reis RL, Correlo VM. Melanin nanoparticles as a promising tool for biomedical applications - a review. Acta biomaterialia. 2020;105:26–43. doi:10.1016/j.actbio.2020.01.044
   PubMedGoogle Scholar
• Wang X, Wang C, Wang X, Wang Y, Zhang Q, Cheng Y. A polydopamine nanoparticle-knotted poly(ethylene glycol) hydrogel for on-demand drug delivery and chemo-photothermal therapy. Chem Mater. 2017;29(3):1370–1376. doi:10.1021/acs.chemmater.6b05192
   Web of Science ®Google Scholar
• Pechanova O, Barta A, Koneracka M, et al. Protective effects of nanoparticle-loaded aliskiren on cardiovascular system in spontaneously hypertensive rats. Molecules. 2019;24(15):2710. doi:10.3390/molecules24152710
   PubMed Web of Science ®Google Scholar
• Mao S, Wang L, Chen P, Lan Y, Guo R, Zhang M. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway. Artif Cells, Nanomed Biotechnol. 2018;46(sup3):S707–s716. doi:10.1080/21691401.2018.1508028
   PubMed Web of Science ®Google Scholar
• Guex AG, Kocher FM, Fortunato G, et al. Fine-tuning of substrate architecture and surface chemistry promotes muscle tissue development. Acta biomaterialia. 2012;8(4):1481–1489. doi:10.1016/j.actbio.2011.12.033
   PubMedGoogle Scholar
• Bae S, Park M, Kang C, et al. Hydrogen peroxide-responsive nanoparticle reduces myocardial ischemia/reperfusion injury. J Am Heart Assoc. 2016;5(11). doi:10.1161/jaha.116.003697
   PubMedGoogle Scholar
• Wu S, Duan B, Qin X, Butcher JT. Living nano-micro fibrous woven fabric/hydrogel composite scaffolds for heart valve engineering. Acta biomaterialia. 2017;51:89–100. doi:10.1016/j.actbio.2017.01.051
   PubMedGoogle Scholar
• Pok S, Vitale F, Eichmann SL, Benavides OM, Pasquali M, Jacot JG. Biocompatible carbon nanotube-chitosan scaffold matching the electrical conductivity of the heart. ACS Nano. 2014;8(10):9822–9832. doi:10.1021/nn503693h
   PubMed Web of Science ®Google Scholar
• Zhu K, Wu M, Lai H, et al. Nanoparticle-enhanced generation of gene-transfected mesenchymal stem cells for in vivo cardiac repair. Biomaterials. 2016;74:188–199. doi:10.1016/j.biomaterials.2015.10.010
   PubMedGoogle Scholar
• Singh B, Garg T, Goyal AK, Rath G. Recent advancements in the cardiovascular drug carriers. Artif Cells, Nanomed Biotechnol. 2016;44(1):216–225. doi:10.3109/21691401.2014.937868
   PubMed Web of Science ®Google Scholar
• Jung H, Jang MK, Nah JW, Kim YB. Synthesis and Characterization of Thermosensitive Nanoparticles Based on PNIPAAm Core and Chitosan Shell Structure. Article. Macromol Res. 2009;17(4):265–270. doi:10.1007/bf03218690
   Google Scholar
• Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK. Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat. 2020;30(3):179–194. doi:10.1080/13543776.2020.1720649
   PubMed Web of Science ®Google Scholar
• Piperigkou Z, Karamanou K, Engin AB, et al. Emerging aspects of nanotoxicology in health and disease: from agriculture and food sector to cancer therapeutics. Food Chem Toxicol. 2016;91:42–57. doi:10.1016/j.fct.2016.03.003
   PubMed Web of Science ®Google Scholar
• Chen W, Jarzyna PA, van Tilborg GA, et al. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB j. 2010;24(6):1689–1699. doi:10.1096/fj.09-139865
   PubMedGoogle Scholar
• Nguyen J, Sievers R, Motion JP, Kivimäe S, Fang Q, Lee RJ. Delivery of lipid micelles into infarcted myocardium using a lipid-linked matrix metalloproteinase targeting peptide. Mol Pharm. 2015;12(4):1150–1157. doi:10.1021/mp500653y
   PubMedGoogle Scholar
• Ashtari K, Nazari H, Ko H, et al. Electrically conductive nanomaterials for cardiac tissue engineering. Adv Drug Deliv Rev. 2019;144:162–179. doi:10.1016/j.addr.2019.06.001
   PubMedGoogle Scholar
• Kinnunen SM, Tölli M, Välimäki MJ, et al. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction. Sci Rep. 2018;8(1):4611. doi:10.1038/s41598-018-22830-8
   PubMedGoogle Scholar
• Dong Y, Hong M, Dai R, Wu H, Zhu P. Engineered bioactive nanoparticles incorporated biofunctionalized ECM/silk proteins based cardiac patches combined with MSCs for the repair of myocardial infarction: in vitro and in vivo evaluations. Sci Total Environ. 2020;707:135976. doi:10.1016/j.scitotenv.2019.135976
   PubMed Web of Science ®Google Scholar
• Ramirez-Lee MA, Aguirre-Bañuelos P, Martinez-Cuevas PP, et al. Evaluation of cardiovascular responses to silver nanoparticles (AgNPs) in spontaneously hypertensive rats. Nanomedicine. 2018;14(2):385–395. doi:10.1016/j.nano.2017.11.013
   PubMedGoogle Scholar
• Sharma AK, Kumar A, Sahu M, Sharma G, Datusalia AK, Rajput SK. Exercise preconditioning and low dose copper nanoparticles exhibits cardioprotection through targeting GSK-3β phosphorylation in ischemia/reperfusion induced myocardial infarction. Microvasc Res. 2018;120:59–66. doi:10.1016/j.mvr.2018.06.003
   PubMed Web of Science ®Google Scholar
• Zhang T, Dang M, Zhang W, Lin X. Gold nanoparticles synthesized from Euphorbia fischeriana root by green route method alleviates the isoprenaline hydrochloride induced myocardial infarction in rats. J Photochem Photobiol B. 2020;202:111705. doi:10.1016/j.jphotobiol.2019.111705
   PubMed Web of Science ®Google Scholar
• Tian A, Yang C, Zhu B, et al. Polyethylene-glycol-coated gold nanoparticles improve cardiac function after myocardial infarction in mice. Can J Physiol Pharmacol. 2018;96(12):1318–1327. doi:10.1139/cjpp-2018-0227
   PubMed Web of Science ®Google Scholar
• Hosoyama K, Ahumada M, Variola F, et al. Nanoengineered Electroconductive Collagen-Based Cardiac Patch for Infarcted Myocardium Repair. ACS Appl Mater Interfaces. 2018;10(51):44668–44677. doi:10.1021/acsami.8b18844
   PubMed Web of Science ®Google Scholar
• You JO, Rafat M, Ye GJ, Auguste DT. Nanoengineering the heart: conductive scaffolds enhance connexin 43 expression. Nano Lett. 2011;11(9):3643–3648. doi:10.1021/nl201514a
   PubMed Web of Science ®Google Scholar
• Zhang BF, Jiang H, Chen J, Hu Q, Yang S, Liu XP. Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction. J Cell Physiol. 2019;234(10):18544–18559. doi:10.1002/jcp.28492
   PubMedGoogle Scholar
• Gao W, Sun Y, Cai M, et al. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis. Nat Commun. 2018;9(1):231. doi:10.1038/s41467-017-02657-z
   PubMed Web of Science ®Google Scholar
• Liu N, Chen J, Zhuang J, Zhu P. Fabrication of engineered nanoparticles on biological macromolecular (PEGylated chitosan) composite for bio-active hydrogel system in cardiac repair applications. Int J Biol Macromol. 2018;117:553–558. doi:10.1016/j.ijbiomac.2018.04.196
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang H, Hu Y, Bai L, Xue J. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction. Int J Nanomedicine. 2018;13:6177–6188. doi:10.2147/ijn.s176404
   PubMed Web of Science ®Google Scholar
• Xiong YY, Gong ZT, Tang RJ, Yang YJ. The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction. Theranostics. 2021;11(3):1046–1058. doi:10.7150/thno.53326
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353–367. doi:10.1093/cvr/cvz139
   PubMed Web of Science ®Google Scholar
• Zhang LL, Xiong YY, Yang YJ. The vital roles of mesenchymal stem cells and the derived extracellular vesicles in promoting angiogenesis after acute myocardial infarction. Stem Cells Dev. 2021;30(11):561–577. doi:10.1089/scd.2021.0006
   PubMedGoogle Scholar
• Rodrigo SF, van Ramshorst J, Hoogslag GE, et al. Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res. 2013;6(5):816–825. doi:10.1007/s12265-013-9507-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Li Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61–69. doi:10.1016/j.ijcard.2015.05.020
   PubMed Web of Science ®Google Scholar
• Huang P, Tian X, Li Q, Yang Y. New strategies for improving stem cell therapy in ischemic heart disease. Heart Fail Rev. 2016;21(6):737–752. doi:10.1007/s10741-016-9576-1
   PubMedGoogle Scholar
• Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009;61(6):457–466. doi:10.1016/j.addr.2009.03.010
   PubMed Web of Science ®Google Scholar
• Sun Y, Lu Y, Yin L, Liu Z. The roles of nanoparticles in stem cell-based therapy for cardiovascular disease. Front Bioengineering Biotechnol. 2020;8:947. doi:10.3389/fbioe.2020.00947
   PubMed Web of Science ®Google Scholar
• Chan CKW, Zhang L, Cheng CK, et al. Recent advances in managing atherosclerosis via nanomedicine. Small. 2018;14(4):1702793. doi:10.1002/smll.201702793
   Web of Science ®Google Scholar
• Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114(14):1504–1511. doi:10.1161/circulationaha.106.646380
   PubMed Web of Science ®Google Scholar
• Pérez-Medina C, Binderup T, Lobatto ME, et al. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. JACC Cardiovasc Imaging. 2016;9(8):950–961. doi:10.1016/j.jcmg.2016.01.020
   PubMedGoogle Scholar
• Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A. 2006;103(13):4930–4934. doi:10.1073/pnas.0600997103
   PubMed Web of Science ®Google Scholar
• Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6(1):12–21. doi:10.1002/smll.200901158
   PubMed Web of Science ®Google Scholar
• Yi S, Allen SD, Liu YG, et al. Tailoring nanostructure morphology for enhanced targeting of dendritic cells in atherosclerosis. ACS Nano. 2016;10(12):11290–11303. doi:10.1021/acsnano.6b06451
   PubMed Web of Science ®Google Scholar
• Palma-Chavez JA, Fuentes K, Applegate BE, Jo JA, Charoenphol P. Development and characterization of PLGA-based multistage delivery system for enhanced payload delivery to targeted vascular endothelium. Macromol Biosci. 2021;21(3):e2000377. doi:10.1002/mabi.202000377
   PubMedGoogle Scholar
• Schöttler S, Becker G, Winzen S, et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372–377. doi:10.1038/nnano.2015.330
   PubMed Web of Science ®Google Scholar
• Zheng Y, Lu L, Yan Z, et al. mPEG-icariin nanoparticles for treating myocardial ischaemia. Artif Cells, Nanomed Biotechnol. 2019;47(1):801–811. doi:10.1080/21691401.2018.1554579
   PubMed Web of Science ®Google Scholar
• Mima Y, Abu Lila AS, Shimizu T, et al. Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity. J Controlled Release. 2017;250:20–26. doi:10.1016/j.jconrel.2017.01.040
   PubMed Web of Science ®Google Scholar
• Wang W, Chen J, Li M, et al. Rebuilding Postinfarcted Cardiac Functions by Injecting TIIA@PDA Nanoparticle-Cross-linked ROS-Sensitive Hydrogels. ACS Appl Mater Interfaces. 2019;11(3):2880–2890. doi:10.1021/acsami.8b20158
   PubMedGoogle Scholar
• Thomas TJ, Tajmir-Riahi HA, Pillai CKS. Biodegradable polymers for gene delivery. Molecules. 2019;24(20):3744. doi:10.3390/molecules24203744
   PubMed Web of Science ®Google Scholar
• Yang X, Yang M, Pang B, Vara M, Xia Y. Gold nanomaterials at work in biomedicine. Chem Rev. 2015;115(19):10410–10488. doi:10.1021/acs.chemrev.5b00193
   PubMed Web of Science ®Google Scholar
• Saludas L, Pascual-Gil S, Roli F, Garbayo E, Blanco-Prieto MJ. Heart tissue repair and cardioprotection using drug delivery systems. Maturitas. 2018;110:1–9. doi:10.1016/j.maturitas.2018.01.011
   PubMed Web of Science ®Google Scholar
• Esfandyari-Manesh M, Abdi M, Talasaz AH, Ebrahimi SM, Atyabi F, Dinarvand R. S2P peptide-conjugated PLGA-Maleimide-PEG nanoparticles containing Imatinib for targeting drug delivery to atherosclerotic plaques. DARU J Pharmaceutical Sci. 2020;28(1):131–138. doi:10.1007/s40199-019-00324-w
   Google Scholar
• Cuadrado I, Piedras MJ, Herruzo I, et al. EMMPRIN-targeted magnetic nanoparticles for in vivo visualization and regression of acute myocardial infarction. Theranostics. 2016;6(4):545–557. doi:10.7150/thno.13352
   PubMedGoogle Scholar
• Ferreira MP, Ranjan S, Correia AM, et al. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Biomaterials. 2016;94:93–104. doi:10.1016/j.biomaterials.2016.03.046
   PubMed Web of Science ®Google Scholar
• Boada C, Zinger A, Tsao C, et al. Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation. Circ Res. 2020;126(1):25–37. doi:10.1161/circresaha.119.315185
   PubMed Web of Science ®Google Scholar
• Matoba T, Koga JI, Nakano K, Egashira K, Tsutsui H. Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease. J Cardiol. 2017;70(3):206–211. doi:10.1016/j.jjcc.2017.03.005
   PubMed Web of Science ®Google Scholar
• Markovsky E, Baabur-Cohen H, Eldar-Boock A, et al. Administration, distribution, metabolism and elimination of polymer therapeutics. J Control Release. 2012;161(2):446–460. doi:10.1016/j.jconrel.2011.12.021
   PubMed Web of Science ®Google Scholar
• Yao Y, Liao W, Yu R, Du Y, Zhang T, Peng Q. Potentials of combining nanomaterials and stem cell therapy in myocardial repair. Nanomedicine. 2018;13(13):1623–1638. doi:10.2217/nnm-2018-0013
   PubMedGoogle Scholar
• Bottini M, Bruckner S, Nika K, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett. 2006;160(2):121–126. doi:10.1016/j.toxlet.2005.06.020
   PubMed Web of Science ®Google Scholar
• Hirano S, Kanno S, Furuyama A. Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol. 2008;232(2):244–251. doi:10.1016/j.taap.2008.06.016
   PubMed Web of Science ®Google Scholar
• Duan J, Yu Y, Yu Y, et al. Silica nanoparticles enhance autophagic activity, disturb endothelial cell homeostasis and impair angiogenesis. Part Fibre Toxicol. 2014;11:50. doi:10.1186/s12989-014-0050-8
   PubMed Web of Science ®Google Scholar
• Duan J, Liang S, Yu Y, et al. Inflammation-coagulation response and thrombotic effects induced by silica nanoparticles in zebrafish embryos. Nanotoxicology. 2018;12(5):470–484. doi:10.1080/17435390.2018.1461267
   PubMed Web of Science ®Google Scholar
• Feng L, Yang X, Liang S, et al. Silica nanoparticles trigger the vascular endothelial dysfunction and prethrombotic state via miR-451 directly regulating the IL6R signaling pathway. Part Fibre Toxicol. 2019;16(1):16. doi:10.1186/s12989-019-0300-x
   PubMedGoogle Scholar
• Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol. 2014;11:11. doi:10.1186/1743-8977-11-11
   PubMed Web of Science ®Google Scholar
• Asharani PV, Lian Y, Gong Z, Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology. 2008;19(25):255102. doi:10.1088/0957-4484/19/25/255102
   PubMed Web of Science ®Google Scholar
• Sereemaspun A, Rojanathanes R, Wiwanitkit V. Effect of gold nanoparticle on renal cell: an implication for exposure risk. Ren Fail. 2008;30(3):323–325. doi:10.1080/08860220701860914
   PubMed Web of Science ®Google Scholar
• Yang C, Tian A, Li Z. Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice. Sci Rep. 2016;6:20203. doi:10.1038/srep20203
   PubMed Web of Science ®Google Scholar
• El-Hussainy HM, Hussein AM, Abdel-Aziz A, El-Mehasseb I. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can J Physiol Pharmacol. 2016;94(8):868–878. doi:10.1139/cjpp-2015-0446
   PubMed Web of Science ®Google Scholar
• Keyoumu Y, Huo Q, Cheng L, et al. The detailed biological investigations about combined effects of novel polyphenolic and photo-plasmonic nanoparticles loaded graphene nanosheets on coronary endothelial cells and isolated rat aortic rings. J Photochem Photobiol B. 2020;202:111666. doi:10.1016/j.jphotobiol.2019.111666
   PubMedGoogle Scholar
• Nemmar A, Beegam S, Yuvaraju P, et al. Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice. Part Fibre Toxicol. 2016;13(1):22. doi:10.1186/s12989-016-0132-x
   PubMedGoogle Scholar
• Babiker F, Benter IF, Akhtar S. Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury. Int J Nanomedicine. 2020;15:4393–4405. doi:10.2147/ijn.s255202
   PubMed Web of Science ®Google Scholar
• Gao L, Gregorich ZR, Zhu W, et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation. 2018;137(16):1712–1730. doi:10.1161/circulationaha.117.030785
   PubMed Web of Science ®Google Scholar
• Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004;15(4):897–900. doi:10.1021/bc049951i
   PubMed Web of Science ®Google Scholar
• Shin SR, Jung SM, Zalabany M, et al. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano. 2013;7(3):2369–2380. doi:10.1021/nn305559j
   PubMed Web of Science ®Google Scholar
• Costa PM, Bourgognon M, Wang JT, Al-Jamal KT. Functionalised carbon nanotubes: from intracellular uptake and cell-related toxicity to systemic brain delivery. J Controlled Release. 2016;241:200–219. doi:10.1016/j.jconrel.2016.09.033
   PubMed Web of Science ®Google Scholar
• Ikeda G, Matoba T, Nakano Y, et al. Nanoparticle-mediated targeting of cyclosporine a enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening. Sci Rep. 2016;6:20467. doi:10.1038/srep20467
   PubMed Web of Science ®Google Scholar
• Maranhão RC, Guido MC, de Lima AD, et al. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. Int J Nanomedicine. 2017;12:3767–3784. doi:10.2147/ijn.S129324
   PubMedGoogle Scholar
• Margulis K, Neofytou EA, Beygui RE, Zare RN. Celecoxib Nanoparticles for Therapeutic Angiogenesis. ACS Nano. 2015;9(9):9416–9426. doi:10.1021/acsnano.5b04137
   PubMedGoogle Scholar
• Tokutome M, Matoba T, Nakano Y, et al. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models. Cardiovasc Res. 2019;115(2):419–431. doi:10.1093/cvr/cvy200
   PubMed Web of Science ®Google Scholar
• Qi Q, Lu L, Li H, et al. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction. Int J Nanomedicine. 2017;12:4835–4848. doi:10.2147/ijn.s132064
   PubMedGoogle Scholar
• Zhang Y, Qian P, Zhou H, et al. Pharmacological signatures of the exenatide nanoparticles complex against myocardial ischemia reperfusion injury. Kidney Blood Press Res. 2018;43(4):1273–1284. doi:10.1159/000492409
   PubMed Web of Science ®Google Scholar
• Ichimura K, Matoba T, Nakano K, et al. A translational study of a new therapeutic approach for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin into reperfused myocardium reduces ischemia-reperfusion injury in a preclinical porcine model. PLoS One. 2016;11(9):e0162425. doi:10.1371/journal.pone.0162425
   PubMedGoogle Scholar
• Cheng Y, Liu DZ, Zhang CX, et al. Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia-reperfusion injury through a multistage continuous targeted strategy. Nanomedicine. 2019;16:236–249. doi:10.1016/j.nano.2018.12.014
   PubMed Web of Science ®Google Scholar
• Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297–304. doi:10.1016/j.biopha.2017.02.029
   PubMed Web of Science ®Google Scholar
• Liu CJ, Yao L, Hu YM, Zhao BT. Effect of quercetin-loaded mesoporous silica nanoparticles on myocardial ischemia-reperfusion injury in rats and its mechanism. Int J Nanomedicine. 2021;16:741–752. doi:10.2147/ijn.s277377
   PubMed Web of Science ®Google Scholar
• Boarescu PM, Chirilă I, Bulboacă AE, et al. Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction. Oxid Med Cell Longev. 2019;2019:7847142. doi:10.1155/2019/7847142
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Matoba T, Koga JI, et al. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice. Cardiovasc Res. 2019;115(7):1244–1255. doi:10.1093/cvr/cvz066
   PubMedGoogle Scholar
• Ferreira MPA, Ranjan S, Kinnunen S, et al. Drug-loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic signaling. Small. 2017;13(33):548. doi:10.1002/smll.201701276
   Google Scholar
• Qiao B, Nie JJ. Functional nanocomplexes with vascular endothelial growth factor a/c isoforms improve collateral circulation and cardiac function. Small. 2020;16(4):e1905925. doi:10.1002/smll.201905925
   PubMedGoogle Scholar
• Ding Y, Zhao AS, Liu T, et al. An Injectable Nanocomposite Hydrogel for Potential Application of Vascularization and Tissue Repair. Ann Biomed Eng. 2020;48(5):1511–1523. doi:10.1007/s10439-020-02471-7
   PubMedGoogle Scholar
• Garbayo E, Pascual-Gil S. Nanomedicine and drug delivery systems in cancer and regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(5):e1637. doi:10.1002/wnan.1637
   PubMed Web of Science ®Google Scholar
• Fang R, Qiao S, Liu Y, et al. Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts. Int J Nanomedicine. 2015;10:4691–4703. doi:10.2147/ijn.s81451
   PubMed Web of Science ®Google Scholar
• Awada HK, Long DW, Wang Z, Hwang MP, Kim K, Wang Y. A single injection of protein-loaded coacervate-gel significantly improves cardiac function post infarction. Biomaterials. 2017;125:65–80. doi:10.1016/j.biomaterials.2017.02.020
   PubMedGoogle Scholar
• Somasuntharam I, Yehl K, Carroll SL, et al. Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction. Biomaterials. 2016;83:12–22. doi:10.1016/j.biomaterials.2015.12.022
   PubMed Web of Science ®Google Scholar
• Kataria K, Sharma A, Garg T, K. goyal A, Rath G. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett. 2014;4(1):79–86. doi:10.2174/22103031113036660018
   Google Scholar
• Kim HJ, Oh HJ, Park JS, Lee JS, Kim JH, Park KH. Direct conversion of human dermal fibroblasts into cardiomyocyte-like cells using CiCMC Nanogels Coupled with Cardiac Transcription Factors and a Nucleoside Drug. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2020;7(7):1901818. doi:10.1002/advs.201901818
   PubMedGoogle Scholar
• Turnbull IC, Eltoukhy AA, Fish KM, et al. Myocardial delivery of lipidoid nanoparticle carrying modrna induces rapid and transient expression. Mol Therapy. 2016;24(1):66–75. doi:10.1038/mt.2015.193
   PubMed Web of Science ®Google Scholar
• Nie JJ, Qiao B, Duan S, et al. Unlockable nanocomplexes with self-accelerating nucleic acid release for effective staged gene therapy of cardiovascular diseases. Adv Materials. 2018;30(31):e1801570. doi:10.1002/adma.201801570
   PubMedGoogle Scholar
• Bejerano T, Etzion S, Elyagon S, Etzion Y, Cohen S. Nanoparticle Delivery of miRNA-21 Mimic to Cardiac Macrophages Improves Myocardial Remodeling after Myocardial Infarction. Nano Lett. 2018;18(9):5885–5891. doi:10.1021/acs.nanolett.8b02578
   PubMed Web of Science ®Google Scholar
• Mirna M, Paar V, Topf A, et al. A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis. Cardiovasc Res. 2021. doi:10.1093/cvr/cvab015
   Google Scholar
• Yang H, Qin X, Wang H, et al. An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium. ACS Nano. 2019;13(9):9880–9894. doi:10.1021/acsnano.9b03343
   PubMed Web of Science ®Google Scholar
• Ma S, Tian XY, Zhang Y, et al. E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis. Sci Rep. 2016;6:22910. doi:10.1038/srep22910
   PubMed Web of Science ®Google Scholar
• Sayed N, Tambe P, Kumar P, Jadhav S, Paknikar KM, Gajbhiye V. miRNA transfection via poly(amidoamine)-based delivery vector prevents hypoxia/reperfusion-induced cardiomyocyte apoptosis. Nanomedicine. 2020;15(2):163–181. doi:10.2217/nnm-2019-0363
   PubMed Web of Science ®Google Scholar
• Xue X, Shi X, Dong H, et al. Delivery of microRNA-1 inhibitor by dendrimer-based nanovector: an early targeting therapy for myocardial infarction in mice. Nanomedicine. 2018;14(2):619–631. doi:10.1016/j.nano.2017.12.004
   PubMedGoogle Scholar
• Dosta P, Demos C, Ramos V, et al. Delivery of siRNA to Endothelial Cells In Vivo Using Lysine/Histidine Oligopeptide-Modified Poly(β-amino ester) Nanoparticles. Cardiovasc Eng Technol. 2021;12(1):114–125. doi:10.1007/s13239-021-00518-x
   PubMedGoogle Scholar
• Lu W, Xie Z, Tang Y, et al. Photoluminescent mesoporous silicon nanoparticles with siCCR2 improve the effects of mesenchymal stromal cell transplantation after acute myocardial infarction. Theranostics. 2015;5(10):1068–1082. doi:10.7150/thno.11517
   PubMedGoogle Scholar
• Izadifar M, Chapman D, Babyn P, Chen X. UV-Assisted 3d bioprinting of nanoreinforced hybrid cardiac patch for myocardial tissue engineering. Tissue Eng Part C Methods. 2018;24(2):74–88. doi:10.1089/ten.TEC.2017.0346
   PubMed Web of Science ®Google Scholar
• Ho CM, Mishra A, Lin PT, et al. 3D Printed polycaprolactone carbon nanotube composite scaffolds for cardiac tissue engineering. Macromol Biosci. 2017;17(4):1600250. doi:10.1002/mabi.201600250
   Web of Science ®Google Scholar
• Kharaziha M, Shin SR, Nikkhah M, et al. Tough and flexible CNT-polymeric hybrid scaffolds for engineering cardiac constructs. Biomaterials. 2014;35(26):7346–7354. doi:10.1016/j.biomaterials.2014.05.014
   PubMed Web of Science ®Google Scholar
• Navaei A, Saini H, Christenson W, Sullivan RT, Ros R, Nikkhah M. Gold nanorod-incorporated gelatin-based conductive hydrogels for engineering cardiac tissue constructs. Acta biomaterialia. 2016;41:133–146. doi:10.1016/j.actbio.2016.05.027
   PubMed Web of Science ®Google Scholar
• Ahadian S, Davenport Huyer L, Estili M, et al. Moldable elastomeric polyester-carbon nanotube scaffolds for cardiac tissue engineering. Acta biomaterialia. 2017;52:81–91. doi:10.1016/j.actbio.2016.12.009
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen J, Sun H, et al. Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function. Sci Rep. 2014;4:3733. doi:10.1038/srep03733
   PubMed Web of Science ®Google Scholar
• Baei P, Jalili-Firoozinezhad S, Rajabi-Zeleti S, Tafazzoli-Shadpour M, Baharvand H, Aghdami N. Electrically conductive gold nanoparticle-chitosan thermosensitive hydrogels for cardiac tissue engineering. Mater Sci Eng C Mater Biol Appl. 2016;63:131–141. doi:10.1016/j.msec.2016.02.056
   PubMed Web of Science ®Google Scholar
• Navaei A, Rahmani Eliato K, Ros R, Migrino RQ, Willis BC, Nikkhah M. The influence of electrically conductive and non-conductive nanocomposite scaffolds on the maturation and excitability of engineered cardiac tissues. Biomaterials sci. 2019;7(2):585–595. doi:10.1039/c8bm01050a
   PubMedGoogle Scholar
• Martinelli V, Cellot G, Toma FM, et al. Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myocytes. Nano Lett. 2012;12(4):1831–1838. doi:10.1021/nl204064s
   PubMed Web of Science ®Google Scholar
• Peña B, Maldonado M, Bonham AJ, et al. Gold Nanoparticle-Functionalized Reverse Thermal Gel for Tissue Engineering Applications. ACS Appl Mater Interfaces. 2019;11(20):18671–18680. doi:10.1021/acsami.9b00666
   PubMed Web of Science ®Google Scholar
• Mombini S, Mohammadnejad J, Bakhshandeh B, et al. Chitosan-PVA-CNT nanofibers as electrically conductive scaffolds for cardiovascular tissue engineering. Int J Biol Macromol. 2019;140:278–287. doi:10.1016/j.ijbiomac.2019.08.046
   PubMed Web of Science ®Google Scholar
• Thrivikraman G, Madras G, Basu B. Electrically driven intracellular and extracellular nanomanipulators evoke neurogenic/cardiomyogenic differentiation in human mesenchymal stem cells. Biomaterials. 2016;77:26–43. doi:10.1016/j.biomaterials.2015.10.078
   PubMedGoogle Scholar
• Li Y, Shi X, Tian L, et al. AuNP-collagen matrix with localized stiffness for cardiac-tissue engineering: enhancing the assembly of intercalated discs by β1-integrin-mediated signaling. Adv Materials. 2016;28(46):10230–10235. doi:10.1002/adma.201603027
   PubMedGoogle Scholar
• Allison S, Ahumada M, Andronic C, et al. Electroconductive nanoengineered biomimetic hybrid fibers for cardiac tissue engineering. J Materials Chem B. 2017;5(13):2402–2406. doi:10.1039/c7tb00405b
   PubMed Web of Science ®Google Scholar
• Xu JY, Xiong YY, Lu XT, Yang YJ. Regulation of Type 2 Immunity in Myocardial Infarction. Front Immunol. 2019;10:62. doi:10.3389/fimmu.2019.00062
   PubMed Web of Science ®Google Scholar
• Li X, Zhou J, Liu Z, et al. A PNIPAAm-based thermosensitive hydrogel containing SWCNTs for stem cell transplantation in myocardial repair. Biomaterials. 2014;35(22):5679–5688. doi:10.1016/j.biomaterials.2014.03.067
   PubMed Web of Science ®Google Scholar
• Kalishwaralal K, Jeyabharathi S, Sundar K, Selvamani S, Prasanna M, Muthukumaran A. A novel biocompatible chitosan-Selenium nanoparticles (SeNPs) film with electrical conductivity for cardiac tissue engineering application. Mater Sci Eng C Mater Biol Appl. 2018;92:151–160. doi:10.1016/j.msec.2018.06.036
   PubMedGoogle Scholar
• Nazari H, Heirani-Tabasi A, Hajiabbas M, et al. Incorporation of SPION-casein core-shells into silk-fibroin nanofibers for cardiac tissue engineering. J Cell Biochem. 2020;121(4):2981–2993. doi:10.1002/jcb.29553
   PubMed Web of Science ®Google Scholar
• Mou Y, Lv S, Xiong F, et al. Effects of different doses of 2,3-dimercaptosuccinic acid-modified Fe(2) O(3) nanoparticles on intercalated discs in engineered cardiac tissues. J Biomed Mater Res B Appl Biomater. 2018;106(1):121–130. doi:10.1002/jbm.b.33757
   PubMedGoogle Scholar
• Chouhan D, Mehrotra S, Majumder O. Magnetic actuator device assisted modulation of cellular behavior and tuning of drug release on silk platform. ACS Biomater Sci Eng. 2019;5:92–105. doi:10.1021/acsbiomaterials.8b00240
   PubMedGoogle Scholar
• Zwi-Dantsis L, Wang B, Marijon C, et al. Remote magnetic nanoparticle manipulation enables the dynamic patterning of cardiac tissues. Adv Materials. 2020;32(6):e1904598. doi:10.1002/adma.201904598
   PubMedGoogle Scholar
• McClements DJ. Designing biopolymer microgels to encapsulate, protect and deliver bioactive components: physicochemical aspects. Adv Colloid Interface Sci. 2017;240:31–59. doi:10.1016/j.cis.2016.12.005
   PubMed Web of Science ®Google Scholar
• Wang L, Jiang J, Hua W. Mussel-inspired conductive cryogel as cardiac tissue patch to repair myocardial infarction by migration of conductive nanoparticles. Adv Funct Mater. 2016;26:4293–4305. doi:10.1002/adfm.201505372
   Web of Science ®Google Scholar
• He Y, Ye G, Song C, et al. Mussel-inspired conductive nanofibrous membranes repair myocardial infarction by enhancing cardiac function and revascularization. Theranostics. 2018;8(18):5159–5177. doi:10.7150/thno.27760
   PubMedGoogle Scholar
• Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–705. doi:10.1038/35070587
   PubMed Web of Science ®Google Scholar
• Xu J, Xiong YY, Li Q, et al. Optimization of timing and times for administration of atorvastatin-pretreated mesenchymal stem cells in a preclinical model of acute myocardial infarction. Stem Cells Transl Med. 2019;8(10):1068–1083. doi:10.1002/sctm.19-0013
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Melnichenko AA, Orekhov AN, Bobryshev YV. Engineered nanoparticles: their properties and putative applications for therapeutic approaches utilizing stem cells for the repair of atherosclerotic disease. Nat Biomed Eng. 2018;19(14):1639–1648. doi:10.2174/1389450118666171027111528
   Google Scholar
• Vandergriff AC, Hensley TM, Henry ET, et al. Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials. 2014;35(30):8528–8539. doi:10.1016/j.biomaterials.2014.06.031
   PubMed Web of Science ®Google Scholar
• Cheng K, Shen D, Hensley MT, et al. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat Commun. 2014;5:4880. doi:10.1038/ncomms5880
   PubMed Web of Science ®Google Scholar
• Chen F, Zhao ER, Hableel G, et al. Increasing the Efficacy of Stem Cell Therapy via Triple-Function Inorganic Nanoparticles. ACS Nano. 2019;13(6):6605–6617. doi:10.1021/acsnano.9b00653
   PubMedGoogle Scholar
• Wang J, Xiang B, Deng JX, et al. Hypoxia enhances the therapeutic potential of superparamagnetic iron oxide-labeled adipose-derived stem cells for myocardial infarction. J Huazhong Univ Sci Technol Med Sci. 2017;37(4):516–522. doi:10.1007/s11596-017-1766-0
   PubMedGoogle Scholar
• Li H, Liao Y, Gao L, et al. Coronary serum exosomes derived from patients with myocardial ischemia regulate angiogenesis through the mir-939-mediated nitric oxide signaling pathway. Theranostics. 2018;8(8):2079–2093. doi:10.7150/thno.21895
   PubMed Web of Science ®Google Scholar
• Cheng M, Yang J, Zhao X, et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat Commun. 2019;10(1):959. doi:10.1038/s41467-019-08895-7
   PubMedGoogle Scholar
• Chen GH, Xu J, Yang YJ. Exosomes: promising sacks for treating ischemic heart disease? Am J Physiol Heart Circ Physiol. 2017;313(3):H508–h523. doi:10.1152/ajpheart.00213.2017
   PubMedGoogle Scholar
• Xu JY, Chen GH, Yang YJ. Exosomes: a rising star in falling hearts. Front Physiol. 2017;8:494. doi:10.3389/fphys.2017.00494
   PubMed Web of Science ®Google Scholar
• Tan SJO, Floriano JF, Nicastro L, Emanueli C, Catapano F. Novel applications of mesenchymal stem cell-derived exosomes for myocardial infarction therapeutics. Biomolecules. 2020;10(5). doi:10.3390/biom10050707
   Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–2051. doi:10.1161/atvbaha.108.179705
   PubMed Web of Science ®Google Scholar
• Allen S, Liu YG, Scott E. Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis. Regenerative Eng Translational Med. 2016;2(1):37–50. doi:10.1007/s40883-016-0012-9
   PubMedGoogle Scholar
• Ning B, Chen Y, Waqar AB, et al. Hypertension enhances advanced atherosclerosis and induces cardiac death in Watanabe heritable hyperlipidemic rabbits. Am J Pathol. 2018;188(12):2936–2947. doi:10.1016/j.ajpath.2018.08.007
   PubMed Web of Science ®Google Scholar
• Martín Giménez VM, Díaz-Rodríguez P, Sanz RL, et al. Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy. Int J Pharm. 2019;566:1–10. doi:10.1016/j.ijpharm.2019.05.047
   PubMedGoogle Scholar
• Yuan LF, Sheng J, Lu P, Wang YQ, Jin T, Du Q. Nanoparticle-mediated RNA interference of angiotensinogen decreases blood pressure and improves myocardial remodeling in spontaneously hypertensive rats. Mol Med Rep. 2015;12(3):4657–4663. doi:10.3892/mmr.2015.3909
   PubMedGoogle Scholar
• Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835
   PubMed Web of Science ®Google Scholar
• Cetin M, Sahin S. Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride. Drug Deliv. 2016;23(8):2796–2805. doi:10.3109/10717544.2015.1089957
   PubMed Web of Science ®Google Scholar
• Li P, Nielsen HM, Fano M, Müllertz A. Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems. J Pharm Sci. 2013;102(8):2689–2698. doi:10.1002/jps.23640
   PubMed Web of Science ®Google Scholar
• Ahn S, Lee IH, Lee E, Kim H, Kim YC, Jon S. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan. J Controlled Release. 2013;170(2):226–232. doi:10.1016/j.jconrel.2013.05.031
   PubMedGoogle Scholar
• Flores AM, Hosseini-Nassab N, Jarr KU, et al. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat Nanotechnol. 2020;15(2):154–161. doi:10.1038/s41565-019-0619-3
   PubMedGoogle Scholar
• Seijkens TTP, van Tiel CM, Kusters PJH, et al. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis. J Am Coll Cardiol. 2018;71(5):527–542. doi:10.1016/j.jacc.2017.11.055
   PubMed Web of Science ®Google Scholar
• Kona S, Dong JF, Liu Y, Tan J, Nguyen KT. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int J Pharm. 2012;423(2):516–524. doi:10.1016/j.ijpharm.2011.11.043
   PubMedGoogle Scholar
• Sager HB, Dutta P, Dahlman JE, et al. RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. Sci Transl Med. 2016;8(342):342ra80. doi:10.1126/scitranslmed.aaf1435
   PubMedGoogle Scholar
• Nakashiro S, Matoba T, Umezu R, et al. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. Arterioscler Thromb Vasc Biol. 2016;36(3):491–500. doi:10.1161/atvbaha.115.307057
   PubMedGoogle Scholar
• Winter PM, Caruthers SD, Zhang H, Williams TA, Wickline SA, Lanza GM. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. JACC Cardiovasc Imaging. 2008;1(5):624–634. doi:10.1016/j.jcmg.2008.06.003
   PubMed Web of Science ®Google Scholar
• Ji J, Yang JA, He X, Ling WP, Chen XL. Cardiac-targeting transfection of tissue-type plasminogen activator gene to prevent the graft thrombosis and vascular anastomotic restenosis after coronary bypass. Thromb Res. 2014;134(2):440–448. doi:10.1016/j.thromres.2014.04.018
   PubMedGoogle Scholar
• Pan H, Palekar RU, Hou KK, et al. Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice. Int J Nanomedicine. 2018;13:5187–5205. doi:10.2147/ijn.S168556
   PubMed Web of Science ®Google Scholar
• Ferdous Z, Al-Salam S, Greish YE, Ali BH, Nemmar A. Pulmonary exposure to silver nanoparticles impairs cardiovascular homeostasis: effects of coating, dose and time. Toxicol Appl Pharmacol. 2019;367:36–50. doi:10.1016/j.taap.2019.01.006
   PubMedGoogle Scholar
• Rossi S, Savi M, Mazzola M, et al. Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats. Particle Fibre Toxicol. 2019;16(1):25. doi:10.1186/s12989-019-0311-7
   PubMedGoogle Scholar
• Nakano Y, Matoba T, Tokutome M, et al. Nanoparticle-mediated delivery of irbesartan induces cardioprotection from myocardial ischemia-reperfusion injury by antagonizing monocyte-mediated inflammation. Sci Rep. 2016;6:29601. doi:10.1038/srep29601
   PubMed Web of Science ®Google Scholar
• Tong F, Liu S, Yan B, Li X, Ruan S, Yang S. Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus. Int J Nanomedicine. 2018;13:2507–2520. doi:10.2147/ijn.s160848
   PubMed Web of Science ®Google Scholar
• Huang Z, Song Y, Pang Z, et al. Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles. Int J Nanomedicine. 2017;12:3023–3036. doi:10.2147/ijn.S131949
   PubMed Web of Science ®Google Scholar
• Bei W, Jing L, Chen N. Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation. Colloids Surf B Biointerfaces. 2020;185:110635. doi:10.1016/j.colsurfb.2019.110635
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 2016;23(9):3696–3703. doi:10.2147/ijn.s131893
   PubMed Web of Science ®Google Scholar
• Qiu J, Cai G, Liu X, Ma D. α(v)β(3) integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia. Biomed Pharmacother. 2017;96:1418–1426. doi:10.1016/j.biopha.2017.10.086
   PubMed Web of Science ®Google Scholar
• Shao M, Yang W, Han G. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles. Int J Nanomedicine. 2017;12:7121–7130. doi:10.2147/ijn.S141549
   PubMed Web of Science ®Google Scholar
• Tan ME, He CH, Jiang W, et al. Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia-reperfusion injury in rats. Int J Nanomedicine. 2017;12:3253–3265. doi:10.2147/ijn.s131893
   PubMed Web of Science ®Google Scholar
• Vinodhini A, Govindaraju K, Singaravelu G, Sadiq AM, Kumar VG. Cardioprotective potential of biobased gold nanoparticles. Colloids Surf B Biointerfaces. 2014;117:480–486. doi:10.1016/j.colsurfb.2014.01.006
   PubMedGoogle Scholar
• Mihalko E, Huang K, Sproul E, Cheng K, Brown AC. Targeted Treatment of Ischemic and Fibrotic Complications of Myocardial Infarction Using a Dual-Delivery Microgel Therapeutic. ACS Nano. 2018;12(8):7826–7837. doi:10.1021/acsnano.8b01977
   PubMedGoogle Scholar
• Ishikita A, Matoba T, Ikeda G, et al. Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: a New Therapeutic Modality for Acute Myocardial Infarction. J Am Heart Assoc. 2016;5(7). doi:10.1161/jaha.116.003872
   PubMedGoogle Scholar
• Asanuma H, Sanada S, Yoshitomi T, et al. Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts. Cardiovascular Drugs and Therapy. 2017;31(5–6):501–510. doi:10.1007/s10557-017-6758-6
   PubMedGoogle Scholar
• Swyer TW, Strom J, Larson DF. Nanoparticle oxygen delivery to the ischemic heart. Perfusion. 2014;29(6):539–543. doi:10.1177/0267659114534290
   PubMedGoogle Scholar
• Yu J, Li W, Yu D. Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation. Drug Des Devel Ther. 2018;12:1697–1706. doi:10.2147/dddt.s166749
   PubMed Web of Science ®Google Scholar
• Lee YS, Choi JW, Oh JE, Yun CO, Kim SW. Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats. Biomaterials. 2016;97:164–175. doi:10.1016/j.biomaterials.2016.04.025
   PubMedGoogle Scholar
• Krohn-Grimberghe M, Mitchell MJ. Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche. Nat Biomed Eng. 2020;4(11):1076–1089. doi:10.1038/s41551-020-00623-7
   PubMed Web of Science ®Google Scholar
• Zhou LS, Zhao GL, Liu Q, Jiang SC, Wang Y, Zhang DM. Silencing collapsin response mediator protein-2 reprograms macrophage phenotype and improves infarct healing in experimental myocardial infarction model. J Inflammation. 2015;12:11. doi:10.1186/s12950-015-0053-8
   Google Scholar
• Courties G, Heidt T, Sebas M, et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol. 2014;63(15):1556–1566. doi:10.1016/j.jacc.2013.11.023
   PubMed Web of Science ®Google Scholar
• Zhu K, Lai H, Guo C, et al. Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair. Int J Nanomedicine. 2014;9:5203–5215. doi:10.2147/ijn.s71586
   PubMedGoogle Scholar
• Hao T, Li J, Yao F, et al. Injectable Fullerenol/Alginate Hydrogel for Suppression of Oxidative Stress Damage in Brown Adipose-Derived Stem Cells and Cardiac Repair. ACS Nano. 2017;11(6):5474–5488. doi:10.1021/acsnano.7b00221
   PubMed Web of Science ®Google Scholar
• Yin Q, Pei Z, Wang H, Zhao Y. Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model. Int J Nanomedicine. 2014;9:17–26. doi:10.2147/ijn.S52005
   PubMedGoogle Scholar
• Ma Q, Yang J, Huang X, et al. Poly(Lactide-Co-Glycolide)-Monomethoxy-Poly-(Polyethylene Glycol) Nanoparticles Loaded with Melatonin Protect Adipose-Derived Stem Cells Transplanted in Infarcted Heart Tissue. Stem Cells. 2018;36(4):540–550. doi:10.1002/stem.2777
   PubMedGoogle Scholar
• Ishii M, Shibata R, Shimizu Y, et al. Multilayered adipose-derived regenerative cell sheets created by a novel magnetite tissue engineering method for myocardial infarction. Int J Cardiol. 2014;175(3):545–553. doi:10.1016/j.ijcard.2014.06.034
   PubMedGoogle Scholar
• Mao Y, Hu Y, Feng W, et al. Effects and mechanisms of PSS-loaded nanoparticles on coronary microcirculation dysfunction in streptozotocin-induced diabetic cardiomyopathy rats. Biomed Pharmacother. 2020;121:109280. doi:10.1016/j.biopha.2019.109280
   PubMed Web of Science ®Google Scholar
• Czyzynska-Cichon I, Janik-Hazuka M, Szafraniec-Szczęsny J, et al. Low Dose Curcumin Administered in Hyaluronic Acid-Based Nanocapsules Induces Hypotensive Effect in Hypertensive Rats. Int J Nanomedicine. 2021;16:1377–1390. doi:10.2147/ijn.S291945
   PubMed Web of Science ®Google Scholar
• Tadin-Strapps M, Robinson M, Le Voci L, et al. Development of lipoprotein(a) siRNAs for mechanism of action studies in non-human primate models of atherosclerosis. J Cardiovasc Transl Res. 2015;8(1):44–53. doi:10.1007/s12265-014-9605-1
   PubMedGoogle Scholar
• Dudhipala N, Veerabrahma K. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv. 2016;23(2):395–404. doi:10.3109/10717544.2014.914986
   PubMed Web of Science ®Google Scholar
• Chen Y, Zeng Y, Zhu X, et al. Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: the basis of better selection of atherosclerosis treatment. Bioactive Materials. 2021;6(3):880–889. doi:10.1016/j.bioactmat.2020.09.005
   PubMedGoogle Scholar
• Akhlaghi S, Rabbani S, Alavi S, et al. Green formulation of curcumin loaded lipid-based nanoparticles as a novel carrier for inhibition of post-angioplasty restenosis. Mater Sci Eng C Mater Biol Appl. 2019;105:110037. doi:10.1016/j.msec.2019.110037
   PubMed Web of Science ®Google Scholar
• Di Francesco V, Gurgone D, Palomba R, et al. Modulating Lipoprotein Transcellular Transport and Atherosclerotic Plaque Formation in ApoE(-/-) Mice via Nanoformulated Lipid-Methotrexate Conjugates. ACS Appl Mater Interfaces. 2020;12(34):37943–37956. doi:10.1021/acsami.0c12202
   PubMedGoogle Scholar
• Mishra S, Bedja D, Amuzie C, et al. Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor. Biomaterials. 2015;64:125–135. doi:10.1016/j.biomaterials.2015.06.001
   PubMedGoogle Scholar
• Barbieri LR, Lourenço-Filho DD, Tavares ER, et al. Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart. Ann Thorac Surg. 2017;104(2):577–583. doi:10.1016/j.athoracsur.2016.12.044
   PubMedGoogle Scholar
• Gomes FLT, Maranhão RC, Tavares ER, et al. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles. J Cardiovasc Pharmacol Ther. 2018;23(6):561–569. doi:10.1177/1074248418778836
   PubMedGoogle Scholar
• Daminelli EN, Martinelli AE, Bulgarelli A, Freitas FR, Maranhão RC. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles. Cardiovascular Drugs and Therapy. 2016;30(5):433–443. doi:10.1007/s10557-016-6675-0
   PubMedGoogle Scholar
• Huang Y, Yu L, Ren J, et al. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy. J Controlled Release. 2019;300:1–12. doi:10.1016/j.jconrel.2019.02.033
   PubMedGoogle Scholar